SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

Share Price is delayed by 15 minutes
Get Live Data
652.00    12.00 (1.88%)
Bid:
644.00
Ask:
660.00
Spread: 16.00 (2.484%)
Market Cap: £219.22m
AVG Live PriceLast checked at - London Stock Exchange

Intraday Avingtrans Share Chart

Adaptix receives CE Certification

12 May 2026 07:00

RNS Number : 8552D
Avingtrans PLC
12 May 2026
 

12 May 2026

 

Avingtrans plc

 

("Avingtrans", the "Company", or the "Group")

 

Adaptix receives CE Certification

 

Avingtrans plc (AIM: AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, is pleased to announce that its subsidiary Adaptix Limited ("Adaptix") has received CE certification for the Adaptix Ortho350, its breakthrough orthopaedic 3D imaging system.

 

Based in the Oxford University Science Park, Adaptix is on a mission to transform radiology by offering affordable, low-dose 3D Digital Tomosynthesis (DT) imaging at the point-of-care.

 

Securing CE certification demonstrates that the Adaptix Ortho350 meets the stringent safety, health and environmental protection requirements of the European Union and the United Kingdom. This enables Adaptix to commercialise its technology across key European and UK healthcare markets.

 

The Adaptix Ortho350 is a compact, mobile Digital Tomosynthesis (DT) system designed to deliver fast, low dose, high resolution 3D X-ray imaging at the point of care. Developed specifically for imaging upper and lower extremities, hands, elbows, shoulders, knees and feet, at a fraction of the radiation dose of traditional CT systems and at a more reasonable cost. The Adaptix Ortho350 system provides clinicians with clearer images than 2D X-ray systems, accelerated patient workflow and enhanced diagnostic confidence.

 

Adaptix already supplies its core 3D imaging technology to the veterinary and industrial nondestructive testing markets via its Adaptix VetSA3D and Adaptix NDT3D product lines. The CE certification marks a major inflection point, opening up the human imaging market for its technology in the UK and Europe paving the way for revenue expansion and strengthened commercial partnerships across the region.

 

Stuart Gall, CEO of Avingtrans PLC Medical and Industrial Imaging Division, said:

"Receiving our CE certificate for the Adaptix Ortho350 is a defining moment for the company in our mission to transform radiology. This approval enables us to bring truly disruptive, low dose 3D imaging directly to clinicians and patients in the UK and Europe. For our shareholders, this milestone unlocks significant commercial opportunities and accelerates our pathway toward scaled adoption in human healthcare. We are extremely proud to move into this next phase of growth in delivering "3D-First" enhanced orthopaedic DT imaging across Primary Care, Emergency Departments and Outpatient settings."

 

- ENDS -

Enquiries:

Avingtrans plc

013 5469 2391

Roger McDowell, Chairman

Steve McQuillan, Chief Executive Officer

Stephen King, Chief Financial Officer

 

 

Singer Capital Markets (Nominated Adviser and Broker)

020 7496 3000

Shaun Dobson

Alex Bond

 

 

IFC Advisory (Financial PR)

 

020 3934 6630

Graham Herring

Tim Metcalfe

Zach Cohen

 

 

 

About Adaptix Ltd

Adaptix Ltd is a UK-based innovator transforming radiology with portable, low dose 3D X-ray imaging that delivers richer diagnostic insight at the point of care. Using digital tomosynthesis, the Adaptix imaging systems provide 3D visualization at doses and costs comparable to traditional 2D X-ray, supporting applications across medical, veterinary, and industrial sectors. Adaptix's mission is to make advanced imaging accessible anytime, anywhere, reshaping diagnostic pathways and enabling faster, more confident decision-making.

Adaptix Ortho350 Imaging Systems

 

Adaptix's orthopaedic 3D imaging solution provides rapid, low dose, point of care diagnostics for extremities, offering clearer multi-layer views than traditional 2D X-ray. The portable system enhances diagnostic accuracy, speeds decision-making, and supports weightbearing imaging, helping clinicians deliver faster, more confident fracture and joint assessments.

 

More information on Adaptix Ltd and 3D imaging technology can be found by visiting their website: www.adaptix.com

 

About Avingtrans plc: 

 

Avingtrans designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial markets worldwide. 

 

Business units

 

Hayward Tyler - Luton, East Kilbride UK, USA, China and India

Specialises in the design, manufacture and servicing of performance-critical motors and pumps for challenging environments. 

Energy Steel, Inc - Rochester Hills, Michigan, USA

Provider of custom fabrications for the nuclear industry, specialising in: OEM parts obsolescence; custom fabrications; engineering design solutions; product refurbishment; on-site technical support. 

Stainless Metalcraft Ltd - Chatteris, UK

Provider of safety-critical equipment for the energy, medical, science and research communities, worldwide, specialising in precision pressure and vacuum vessels and associated fabrications, sub-assemblies and systems. 

Booth Industries - Bolton, UK

Designs, manufactures, installs and services doors and walls which can be tailored to be: blast and explosion proof; fireproof; acoustically shielded; high security/safety; or combinations of the above.

Ormandy Group - Bradford, UK

Design, manufacturers and servicing of off-site plant, heat exchangers and other HVAC (heating, ventilation and air conditioning) products.

Slack & Parr - Kegworth, UK, USA & China

Design, manufacture and servicing of high-precision gear metering pumps, hydraulics flow dividers and industrial pumps.

Composite Products Ltd - Buckingham, UK

Centre for composite technology, parts and assemblies, serving customers in industrial markets.

Adaptix Ltd - Oxford, UK

Adaptix has developed novel 3D X-ray for Orthopaedic and Veterinary applications amongst others. Commercialisation of this system (and others) is on-going.

Magnetica Ltd - Brisbane, Australia

Magnetica Limited specialises in the development of next generation MRI technologies, including dedicated extremity MRI systems and MRI system components. Magnetica has successfully built and tested a compact, integrated 3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging. Commercialisation of this system (and others) is on-going. Magnetica's structure now includes two other business units: 

Scientific Magnetics - Abingdon, UK

Designs and manufactures superconducting magnet systems and associated cryogenics for a variety of markets including MRI and provides services for Nuclear Magnetic Resonance instruments.

Tecmag Inc - Houston, USA

Designs, manufactures and installs instrumentation, including consoles, system upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) systems.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFZGMKKMRGVZM
Date   Source Headline
19th May 202610:20 amRNSHolding(s) in Company
14th May 202612:26 pmRNSHolding(s) in Company
12th May 20267:00 amRNSAdaptix receives CE Certification
6th May 20264:28 pmRNSHolding(s) in Company
30th Apr 20262:42 pmRNSHolding(s) in Company
30th Apr 20262:41 pmRNSExercise of Options & TVR
24th Apr 20262:54 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSStrong Nuclear Orders for Avingtrans
26th Mar 20267:00 amRNS-RScientific Magnetics Ships 20th Quantum Magnet
4th Mar 20267:00 amRNSHolding(s) in Company
25th Feb 20267:00 amRNSInterim Results
12th Feb 202611:49 amRNSHolding(s) in Company
6th Feb 202610:24 amRNSHolding(s) in Company
27th Jan 20265:42 pmRNSExercise of Options & TVR
21st Jan 20267:00 amRNSTrading Update and Notice of Results
12th Jan 20265:13 pmRNSIssue of Share Options
12th Jan 20267:00 amRNS-RMedical & Industrial Imaging Division Appointment
8th Dec 20252:34 pmRNSNotification of Major Holdings
27th Nov 20251:59 pmRNSResult of AGM - Board Appointment
14th Nov 20258:38 amRNSExercise of Options & PDMR Dealings
10th Nov 20257:00 amRNSAdaptix receives FDA 510(K) clearance
1st Oct 20254:52 pmRNSExercise of Options & Total Voting Rights
1st Oct 20253:32 pmRNSHolding(s) in Company
29th Sep 20257:00 amRNSAppointment of Medical Division CEO
24th Sep 20257:00 amRNSPreliminary results for the year ended 31 May 2025
11th Sep 20258:00 amRNSHolding(s) in Company
2nd Sep 20257:00 amRNSHayward Tyler Secures $16m Nuclear Contracts
28th Aug 20257:00 amRNSBooth Industries secures £8.5m HS2 & TfL contracts
25th Jun 20257:00 amRNSTrading Update and Notice of Results
28th May 20257:00 amRNSTrading Update
26th Feb 20257:00 amRNSInterim Results
13th Feb 20257:00 amRNSBooth Industries secures £4.5m Contract
16th Jan 20257:00 amRNSTrading Update & Notice of Results
21st Nov 20244:09 pmRNSResult of AGM
24th Oct 20249:07 amRNSHolding(s) in Company
25th Sep 20247:00 amRNSPreliminary results for the year ended 31 May 2024
3rd Jul 20247:00 amRNSPDMR Dealings
19th Jun 20247:00 amRNSTrading Update and Notice of Results
26th Mar 202411:15 amRNSPDMR Dealings
21st Mar 20245:15 pmRNSExercise of Options, PDMR Dealings & TVR
20th Mar 20243:39 pmRNSHolding(s) in Company
4th Mar 20246:10 pmRNSPDMR Dealings
28th Feb 20247:00 amRNSInterim Results
18th Jan 20247:00 amRNSTrading Update and Notice of Results
15th Dec 20233:00 pmRNSExercise of Options & TVR
4th Dec 20237:00 amRNSMagnetica Limited appoints US distributor
22nd Nov 20237:00 amRNSEmployee & PDMR Share Incentive Awards
16th Nov 20232:20 pmRNSResult of AGM
13th Nov 20237:00 amRNSHayward Tyler Contract Win
11th Oct 20237:00 amRNSContract Wins

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.